Impact of clinical pharmacist integration on diabetes management: a prospective cohort

Abstract Introduction Diabetes is a chronic disease with increasing prevalence. There is growing evidence pharmacist can contribute to clinical outcomes. This study aims to evaluate contribution of pharmacist to prediabetes and diabetes care. Methods A Prospective cohort study designed to evaluate t...

Full description

Saved in:
Bibliographic Details
Main Authors: Nur Burcu Kutluay, Muhammed Yunus Bektay, Betul Sumbul-Sekerci, Abdusselam Sekerci, Fikret Vehbi Izzettin
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-025-12233-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585890808987648
author Nur Burcu Kutluay
Muhammed Yunus Bektay
Betul Sumbul-Sekerci
Abdusselam Sekerci
Fikret Vehbi Izzettin
author_facet Nur Burcu Kutluay
Muhammed Yunus Bektay
Betul Sumbul-Sekerci
Abdusselam Sekerci
Fikret Vehbi Izzettin
author_sort Nur Burcu Kutluay
collection DOAJ
description Abstract Introduction Diabetes is a chronic disease with increasing prevalence. There is growing evidence pharmacist can contribute to clinical outcomes. This study aims to evaluate contribution of pharmacist to prediabetes and diabetes care. Methods A Prospective cohort study designed to evaluate the effects of pharmacist intervention on prediabetes (pDG) and type II diabetes mellitus (DMG) patients. The pharmacist conducted a detailed medication review and structured patient education during the first visit, followed by an evaluation of the interventions at the second visit (after 90 days). The effects were assessed by comparing fasting plasma glucose, HbA1c, the homeostasis model assessment-estimated insulin resistance (HOMA-IR), lipid profile, BMI, waist circumference, illness perception, and diabetes knowledge. Diabetes and preDiabetes knowledge was measured using the Diabetes and preDiabetes Knowledge Measurement Questionnaire (DKMQ and PKMQ), and illness perception with the Illness Perception Questionnaire-Revised (IPQ-R) The effect of pharmacist on diabetes care was assessed with a pre-post intervention comparison. The statistical significance was set at p < 0.05. Results A total of 145 (79 diabetes and 66 prediabetes) patients were included. The mean age of pDG and DMG were 45.79 ± 1.40 and 49.24 ± 1.08 years respectively. A statistically significant improvement was observed in weight, waist circumference, blood glucose, cholesterol, HbA1c, and HOMA-IR levels when comparing pre- and post-pharmacist intervention over the 90-day interval (p < 0.05). Statistically difference was observed in DKMQ, PKMQ and IPQ-R scores among the pDG and DMG (p < 0.001). Conclusion Pharmaceutical care services provided to diabetes patients had positive effects on disease prognosis, knowledge levels and disease perceptions. Patients with HbA1c level higher than 9% had the greatest benefit from pharmacist interventions.
format Article
id doaj-art-025f5d412ef945d799ee1803f3c4e82a
institution Kabale University
issn 1472-6963
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj-art-025f5d412ef945d799ee1803f3c4e82a2025-01-26T12:21:55ZengBMCBMC Health Services Research1472-69632025-01-0125111010.1186/s12913-025-12233-7Impact of clinical pharmacist integration on diabetes management: a prospective cohortNur Burcu Kutluay0Muhammed Yunus Bektay1Betul Sumbul-Sekerci2Abdusselam Sekerci3Fikret Vehbi Izzettin4Clinical Pharmacy Department, Institute of Health Sciences, Bezmialem Vakif UniversityClinical Pharmacy Department, Faculty of Pharmacy, Bezmialem UniversityClinical Pharmacy Department, Faculty of Pharmacy, Bezmialem UniversityInternal Medicine Department, Faculty of Medicine, Bezmialem UniversityClinical Pharmacy Department, Faculty of Pharmacy, Bezmialem UniversityAbstract Introduction Diabetes is a chronic disease with increasing prevalence. There is growing evidence pharmacist can contribute to clinical outcomes. This study aims to evaluate contribution of pharmacist to prediabetes and diabetes care. Methods A Prospective cohort study designed to evaluate the effects of pharmacist intervention on prediabetes (pDG) and type II diabetes mellitus (DMG) patients. The pharmacist conducted a detailed medication review and structured patient education during the first visit, followed by an evaluation of the interventions at the second visit (after 90 days). The effects were assessed by comparing fasting plasma glucose, HbA1c, the homeostasis model assessment-estimated insulin resistance (HOMA-IR), lipid profile, BMI, waist circumference, illness perception, and diabetes knowledge. Diabetes and preDiabetes knowledge was measured using the Diabetes and preDiabetes Knowledge Measurement Questionnaire (DKMQ and PKMQ), and illness perception with the Illness Perception Questionnaire-Revised (IPQ-R) The effect of pharmacist on diabetes care was assessed with a pre-post intervention comparison. The statistical significance was set at p < 0.05. Results A total of 145 (79 diabetes and 66 prediabetes) patients were included. The mean age of pDG and DMG were 45.79 ± 1.40 and 49.24 ± 1.08 years respectively. A statistically significant improvement was observed in weight, waist circumference, blood glucose, cholesterol, HbA1c, and HOMA-IR levels when comparing pre- and post-pharmacist intervention over the 90-day interval (p < 0.05). Statistically difference was observed in DKMQ, PKMQ and IPQ-R scores among the pDG and DMG (p < 0.001). Conclusion Pharmaceutical care services provided to diabetes patients had positive effects on disease prognosis, knowledge levels and disease perceptions. Patients with HbA1c level higher than 9% had the greatest benefit from pharmacist interventions.https://doi.org/10.1186/s12913-025-12233-7Diabetes pharmaceutical carePrediabetesDiabetesClinical pharmacyPatient education
spellingShingle Nur Burcu Kutluay
Muhammed Yunus Bektay
Betul Sumbul-Sekerci
Abdusselam Sekerci
Fikret Vehbi Izzettin
Impact of clinical pharmacist integration on diabetes management: a prospective cohort
BMC Health Services Research
Diabetes pharmaceutical care
Prediabetes
Diabetes
Clinical pharmacy
Patient education
title Impact of clinical pharmacist integration on diabetes management: a prospective cohort
title_full Impact of clinical pharmacist integration on diabetes management: a prospective cohort
title_fullStr Impact of clinical pharmacist integration on diabetes management: a prospective cohort
title_full_unstemmed Impact of clinical pharmacist integration on diabetes management: a prospective cohort
title_short Impact of clinical pharmacist integration on diabetes management: a prospective cohort
title_sort impact of clinical pharmacist integration on diabetes management a prospective cohort
topic Diabetes pharmaceutical care
Prediabetes
Diabetes
Clinical pharmacy
Patient education
url https://doi.org/10.1186/s12913-025-12233-7
work_keys_str_mv AT nurburcukutluay impactofclinicalpharmacistintegrationondiabetesmanagementaprospectivecohort
AT muhammedyunusbektay impactofclinicalpharmacistintegrationondiabetesmanagementaprospectivecohort
AT betulsumbulsekerci impactofclinicalpharmacistintegrationondiabetesmanagementaprospectivecohort
AT abdusselamsekerci impactofclinicalpharmacistintegrationondiabetesmanagementaprospectivecohort
AT fikretvehbiizzettin impactofclinicalpharmacistintegrationondiabetesmanagementaprospectivecohort